ArticleClinical kidney journal2026
Predicting first-year kidney graft loss at the time of donor offer using machine learning and competing-risk analysis in a Latin American cohort.
Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kidney transplantation faces organ shortages, underscoring the need for early risk stratification of graft loss. We developed and validated a 12-month prediction model that treats death as a competing event. Methods: We conducted a retrospective cohort study of 2030 adult kidney transplant recipients (2008-2023) from Colombia's largest transplant network. Models included a random survival forest for competing risks (RSF-CR) and Fine-Gray (FG) regression. Internal validation used stratified cross-validation. Model performance was evaluated via discrimination (C-index), calibration and clinical utility (decision curve analysis). Results: Key predictors included donor type, stroke cause of death (deceased donor), recipient age, donor creatinine, panel reactive antibodies (PRA) class I >20, expanded criteria donor, donor age, years on dialysis, PRA class II >20, donor hypertension, donor-recipient compatibility and retransplantation. The RSF-CR model outperformed the FG, achieving a C-index of 0.87 (versus 0.72) and high sensitivity (88%). It accurately identified low-risk candidates (negative predictive value 98%) and showed a positive net benefit. Conclusion: We developed and validated a predictive model for first-year graft loss in kidney transplant recipients using a machine learning for competing risks model. The model showed strong discriminative ability and moderate calibration. Further temporal validation in our population and external validation in other clinical contexts is required to ensure its applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.